UCDCCC NCTN U10 Program

UCDCCC NCTN U10 项目

基本信息

批准号：
9128209
负责人：
DAVID R GANDARA
金额：
$ 9.97万
依托单位：
UNIVERSITY OF CALIFORNIA AT DAVIS
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-04-14 至 2016-02-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9128209
关键词：
Address American College of Radiology Imaging Network American College of Surgeons Oncology Group Area Awareness Basic Science Biometry California Cancer Center Cancer Control Cancer Patient Catchment Area Center for Translational Science Activities Clinical Clinical Investigator Clinical Nursing Research Clinical Research Clinical Trials Coal Collaborations Communities Comprehensive Cancer Center Ensure Faculty Funding Genomics Goals Gynecologic Oncology Group Health Human Image Intervention Laboratories Lead Leadership Link Malignant Neoplasms Medical Oncology Minority Mission Molecular Biology National Cancer Institute National Clinical Trials Network Pathology Patients Performance Play Population Principal Investigator Radiation Oncology Radiation Therapy Oncology Group Radiology Specialty Research Activity Research Infrastructure Research Personnel Research Support Resources Role Rural Schools Site Southwest Oncology Group Structure Surgical Specialties The Jackson Laboratory Translational Research Translations United States National Institutes of Health Universities Veterinary Medicine Xenograft procedure acronyms base cancer care cancer prevention career development comparative design experience improved innovation laboratory facility medical specialties multidisciplinary oncology program outreach patient population programs research study tertiary care tumor

项目摘要

DESCRIPTION (provided by applicant): As the only NCI-designated cancer center for inland Northern California's approximately 6 million people, the UC Davis Comprehensive Cancer Center (UCDCCC) provides both primary cancer cares to a large and growing population, and serves as the tertiary referral center for specialty cancer care for the region. For this applicatin to become a NCTN Network Lead Academic Participating Site, led by Drs. David R Gandara, MD, and Richard K Valicenti, MD UCDCCC will leverage an already established multidisciplinary team of cancer investigators from medical oncology, radiation oncology, surgical specialties, molecular biology/genomics, pathology, radiology, biostatistics, research nursing, and clinical research support to provide clinical trials expertise, scientific and administrative leadership and accrual in NCTN studies across a broad range of tumor types and throughout the cooperative group network. UCDCCC and its faculty have a long-standing and proven track record of impactful contribution to national cooperative group activities, including SWOG, RTOG, GOG, ACRIN, and ACOSOG, as well as to other NCI-related committees and initiatives. Expanding this effort to the NCTN concept will increase both the scope and reach of participation, including integrating additional researchers and providing career development opportunities for new faculty and junior investigators. Continuing a strong track record in cooperative group translational and clinical research leadership, UCDCCC is poised to exploit unique institutional strengths in serving as a laboratory resource for cooperative group trials and contributing to hypothesis-driven clinical research. Based on over two decades of already serving as the clinical trials "hub" for accrual to NCI-sponsored studies throughout North-Central California, expansion to the NCTN creates a number of additional opportunities for UCDCCC to both increase main site accrual and to extend access to NCTN trials into the community through the UCDCCC Cancer Care Network and affiliate site, which includes substantial underserved, rural and minority patient populations. In summary, UCDCCC represents an interdisciplinary organizational and leadership structure linked to a clinical trials program that will achieve the coals of the NCTN and ensure robust accrual.

描述（由申请人提供）：作为北加州内陆约600万人的NCI指定的癌症中心，UC戴维斯综合癌症中心（UCDCCC）既可以为大量且不断增长的人口提供原发性癌症，并充当该地区的专业癌症护理第三次转诊中心。为了使该应用程序成为由Drs领导的NCTN网络领导学术参与网站。医学博士David R Gandara和MD UCDCCC的Richard K Valicenti将利用已经成立的癌症研究者的多学科研究团队来自医学肿瘤学，放射肿瘤学，手术专业，分子生物学/基因组学/病理学，病理学，放射学，生物统计研究，研究护士和临床研究范围，临床研究范围，科学研究范围，科学研究范围，广泛的肿瘤类型以及整个合作组网络。 UCDCCC及其教职员工对国家合作团体活动的有影响力贡献具有长期良好的记录，包括SWOG，RTOG，GOG，ACRIN和ACOSOG，以及其他与NCI相关的委员会和倡议。将这项工作扩展到NCTN概念将增加参与的范围和范围，包括整合其他研究人员并为新教师和初级研究人员提供职业发展机会。在合作集团翻译和临床研究领导中继续有很强的记录，UCDCCC准备利用独特的机构优势，以作为合作团体试验的实验室资源和有助于假设驱动的临床研究。基于已经作为NCI赞助的整个加利福尼亚州NCI赞助的研究的临床试验“ HUB”的二十年，对NCTN的扩展为UCDCCC创造了许多其他机会，以增加主要现场累积的机会，并通过UCDCCC癌症护理网络和分支机构将NCTN试验扩展到社区中，并将其扩展到社区中，并将其包括实质性的杂物（包括实质性的）（包括实质性的）。总而言之，UCDCCC代表了与临床试验计划相关的跨学科组织和领导结构，该计划将实现NCTN的煤，并确保稳健的应计。